王 静, 陈 洁, 胡 春, et al. PI3K/AKT regulates the expression of PD-L1 via Nrf2 pathway in non-small cell lung cancer[J]. China Oncology, 2020, 30(6): 419-427.
王 静, 陈 洁, 胡 春, et al. PI3K/AKT regulates the expression of PD-L1 via Nrf2 pathway in non-small cell lung cancer[J]. China Oncology, 2020, 30(6): 419-427. DOI: 10.19401/j.cnki.1007-3639.2020.06.003.
PI3K/AKT regulates the expression of PD-L1 via Nrf2 pathway in non-small cell lung cancer
Background and purpose: Programmed death ligand-1 (PD-L1) plays an important role in sheltering tumor cell from surveillance of immune system. While the potential modulation is regarded as being performed at MAPK
PI3K-AKT and STAT3 pathway in most cases
the key control point has never been explicitly reported. This study aimed to probe on this mechanism of lung carcinoma via PI3K/AKT pathway based on the A549 and H460 cell lines. Methods: By using shRNA technology
we created several selectively ‘silent’ mutations of A 549 and H460 cell lines
involving A549
HEB-
A549
HTF4-
A549
Nrf2-
A549
FOXO3a-
H460
HEB-
H460
HTF4-
H460
Nrf2-
and H460
FOXO3a-
. 3’UTR region of PD-L1 was constructed into pGL3-basic vector in order to create a dual luciferase reporter gene system which was able to be used for monitoring the transcriptional activation of PD-L1. Real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) was used to detect the transcriptional level of PD-L1
and the Western blot assay was used for monitoring the total expression of PD-L1; peripheral blood mononuclear cells (PBMCs) co-culturing with A549 and H460 cell lines were utilized to check the function of Nrf2 in tumor immune resistance. Results: Phosphorylation level of AKT and expression level of PD-L1 in A549 and H460 cell lines were simultaneously enhanced after treatment with 10 μg/mL insulin (P0.001)
and the same phenomenon was observed in their mutations with defect in HEB
HTF4 and FOXO3a respectively
however
the plot reversal occurred in A549
Nrf2-
and H460
Nrf2-
cell lines (P0.001). Isoproterenol could boost both transcriptional activation and expression level in A549 and H460 cell lines
and this auto-acti
on was able to be relieved by NAC. Results above further certified the transcriptional regulation of Nrf2 on PD-L1 gene. Wortmannin could change over the function of insulin to raise the expression of PD-L1
by prohibiting the increasing AKT phosphorylation level. Furthermore
the relationship between the phosphorylation level of Nrf2 and AKT was also analyzed by using Wortmannin and insulin
and the results confirmed that the two parties correlated to each other positively
for the correlation coefficient r was 0.86 and 0.93 in A549 and H460 cell lines respectively. At last
A549
Nrf2-
and h460
Nrf2-
cell lines became more sensitive to the attack of PBMCs than that of their wild type owing to Nrf2-deficiency
for increased apoptosis was observed in co-culture experiment. Conclusion: PI3K/AKT pathway plays a vital role in regulating PD-L1 expression in A549 and H460 cell lines
and this action is potentially realized via phosphorylating Nrf2.
Advances in immune checkpoint inhibitor therapy for breast cancer: research progress and future directions
Effect of PD-L1 expression on the efficacy of pemetrexed-based chemotherapy in patients with advanced lung adenocarcinoma and its mechanism
Advances and future prospects of immunotherapy in bladder cancer
Related Author
Cheng ZENG
Yuanyi WANG
Jiani WANG
Fei MA
施茂林
柏玉娣
王 超
李思琪
Related Institution
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College